Clinical Utility of a Low-Cost Hand-Held Breast Scanner
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/7/2018 |
| Start Date: | February 2015 |
| Contact: | Ari Brooks, MD |
| Email: | PennCancerTrials@emergingmed.com |
| Phone: | 855-216-0098 |
Early detection of breast cancer improves the survival rate and makes treatment less costly.
This study would measure the accuracy a low-cost hand-held commercially viable device, iBE,
for the detection of clinically relevant findings in the breast using the results of current
mammography as a comparison. This research will have no impact on clinical decision making.
This study would measure the accuracy a low-cost hand-held commercially viable device, iBE,
for the detection of clinically relevant findings in the breast using the results of current
mammography as a comparison. This research will have no impact on clinical decision making.
Inclusion Criteria:
- 18 years of age and older
- Women and men with symptomatic breast lump (either by palpation or imaging) OR
- Asymptomatic women presenting to the imaging center for a screening mammogram.
- Signed Informed Consent
Exclusion Criteria:
- Patients under 18 years of age
- Patients who previously participated in this study and are returning to the Women's
Imaging Center for follow-up diagnostic tests
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Ari Brooks, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
